Benzinga | Feb 26, 2021 06:04AM EST

Amneal Pharmaceuticals Q4 Adj. EPS $0.14 Beats $0.13 Estimate, Sales $510.00M Beat $507.02M Estimate

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.13 by 7.69 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $510.00 million which beat the analyst consensus estimate of $507.02 million by 0.59 percent. This is a 28.36 percent increase over sales of $397.33 million the same period last year.